PPARγ Agonists as Therapeutics for the Treatment of Alzheimer’s Disease
Neurotherapeutics - United States
doi 10.1016/j.nurt.2008.05.003
Full Text
Open PDFAbstract
Available in full text
Date
July 1, 2008
Authors
Publisher
Springer Science and Business Media LLC